We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

180 hedge funds and large institutions have $973M invested in Cogent Biosciences in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 79 increasing their positions, 36 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more call options, than puts

Call options by funds: $20.5M | Put options by funds: $6.52M

119% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 36

22% more capital invested

Capital invested by funds: $800M → $973M (+$174M)

13% more funds holding in top 10

Funds holding in top 10: 8 → 9 (+1)

1.79% more ownership

Funds ownership: 117.25% → 119.04% (+1.8%)

3% less funds holding

Funds holding: 186 → 180 (-6)

14% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 35

Holders
180
Holders Change
-6
Holders Change %
-3.23%
% of All Funds
2.37%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.12%
New
30
Increased
79
Reduced
36
Closed
35
Calls
$20.5M
Puts
$6.52M
Net Calls
+$13.9M
Net Calls Change
+$15M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$15.8M
2
EA
Emerald Advisers
Pennsylvania
+$8.01M
3
PBA
Paradigm Biocapital Advisors
New York
+$7.7M
4
IC
Ikarian Capital
Texas
+$5.74M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$4.96M

Top Sellers

Rank Fund Capital Flow
1
CC
Commodore Capital
New York
-$36.5M
2
RG
Redmile Group
California
-$9.8M
3
Franklin Resources
Franklin Resources
California
-$7.95M
4
SG Americas Securities
SG Americas Securities
New York
-$5.68M
5
VA
VR Adviser
New York
-$5.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
CWM
151
Crowley Wealth Management
Delaware
$12.2K – – –
Nisa Investment Advisors
152
Nisa Investment Advisors
Missouri
$9.74K +$554 +100 +8%
Comerica Bank
153
Comerica Bank
Texas
$9.13K – – –
LWCFA
154
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$7.18K – – –
FFA
155
Farther Finance Advisors
California
$5.36K +$2.19K +395 +112%
WSFS
156
Wilmington Savings Fund Society
Delaware
$5.24K – – –
CIAM
157
Caitong International Asset Management
Hong Kong
$3.32K +$759 +137 +42%
Daiwa Securities Group
158
Daiwa Securities Group
Japan
$3K – – –
Northwestern Mutual Wealth Management
159
Northwestern Mutual Wealth Management
Wisconsin
$2.87K +$2.22K +400 New
SCM
160
Sterling Capital Management
North Carolina
$2.54K +$859 +155 +78%
GI
161
GAMMA Investing
California
$2.17K -$1.15K -208 -41%
RIL
162
Rothschild Investment LLC
Illinois
$1.98K +$665 +120 +77%
JSAM
163
J. Safra Asset Management
New York
$1.91K – – –
PNC Financial Services Group
164
PNC Financial Services Group
Pennsylvania
$1.73K +$981 +177 +277%
IA
165
IFP Advisors
Florida
$1.35K -$44 -8 Closed
VCM
166
Versant Capital Management
Arizona
$1.22K +$942 +170 New
CPG
167
Cornerstone Planning Group
New Jersey
$1.14K – – –
EP
168
Essential Partners
California
$1.03K +$798 +144 New
S
169
SignatureFD
Georgia
$725 -$610 -110 -52%
SS
170
SBI Securities
Japan
$668 – – –
PFBT
171
Parkside Financial Bank & Trust
Missouri
$510 +$33 +6 +9%
CA
172
CoreCap Advisors
Michigan
$445 – – –
Raymond James Financial
173
Raymond James Financial
Florida
$323 +$249 +45 New
US Bancorp
174
US Bancorp
Minnesota
$223 -$1.08K -195 -86%
MPWT
175
MassMutual Private Wealth & Trust
Connecticut
$208 +$161 +29 New
5 6
7
8 9

COGT Hedge Fund Activity: Q2 2025 in Review

180 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q2 2025, worth a combined $973M — up 22% from $800M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of COGT and 30 opened new positions — a net loss of 5 holders — while 36 trimmed existing stakes and 79 added.

The largest buyer was Janus Henderson Group, adding an estimated $15.8M. The largest seller was Commodore Capital, cutting an estimated $36.5M.

  • 180 institutional investors held Cogent Biosciences (COGT) as of Q2 2025, down from 186 in Q1 2025.
  • Funds reported $973M of Cogent Biosciences stock for Q2 2025, up 22% quarter-over-quarter.
  • 30 funds opened new Cogent Biosciences positions in Q2 2025 and 35 closed out, a net change of -5 holders.
  • The largest Cogent Biosciences buyer in Q2 2025 was Janus Henderson Group, an estimated $15.8M added.
  • The largest Cogent Biosciences seller in Q2 2025 was Commodore Capital, an estimated $36.5M sold.

Based on aggregated 13F filings for Q2 2025.